Rising Demand for Genetic & Complex Disease Treatments Drives the CRISPR Market

CRISPR market size, valued at $2,650 million in 2024, is projected to grow to $8,890 million by 2035, registering a CAGR of 11.6% during 2025–2035. Recent technological advancements in CRISPR & Cas gene systems have revolutionized cancer research and therapeutics. As the prevalence of genetic diseases and complex medical conditions continues to rise, there is an increasing demand for innovative treatments that target the root cause of these ailments. 

Browse the full report description of “CRISPR Market Size, Share & Trends Analysis Report by Application (Cell Line Engineering, CRISPR Plasmid, Gene Database/Gene Library, Genetic Engineering, Genetically Modified Organisms or Crops, Genome Editing, Human Stem Cells), and by End-User (Academic Institutes, Biotechnology Companies, Pharmaceuticals Companies, and Research and Development Institutes), Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/crispr-market

CRISPR-Cas systems are effective and easily programmable for targeting nucleic acids. Several factors have driven the global CRISPR and Cas genes market, including their application in bacterial activities, an increase in research and development expenditures by governments in the field of genome editing, the rising prevalence of genetic diseases, and the application of CRISPR technology to enhance crop production. 

Key Players and Innovations

Several major players lead the CRISPR market, including Beam Therapeutics Inc., CRISPR Therapeutics AG, Editas Medicine, Inc., Genscript Biotech Corp., and Intellia Therapeutics Inc. These companies are at the forefront of innovation, while advancing new technologies to meet the industry's evolving needs. Some of the recent developments in the market include-

• In October 2023, Regeneron Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. collaborated to develop additional in vivo CRISPR-based gene editing therapies focused on treating neurological and muscular diseases.

• In August 2023, the clock.Bio launched its initiative to decode rejuvenation biology across the human genome. The company has developed an aging model that forces human induced pluripotent stem cells (hiPSCs) to activate their self-rejuvenation mechanism. By conducting unbiased CRISPR screens on large samples of these cells, they can identify gene candidates that are causally relevant for cell rejuvenation.

• In November 2021, GenScript Inc. launched the GenWand Double-Stranded DNA (dsDNA) service for manufacturing CRISPR knock-in homology-directed repair (HDR) templates in T-cell engineering. Non-viral vector delivery offers clear advantages, including safety, in CRISPR/Cas applications for gene and cell therapy.

Market Coverage

• The market numbers available for – 2024-2035

• Base year- 2024

• Forecast period- 2025-2035

• Segment Covered- 

o By Application 

o By End-User

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape - Beam Therapeutics Inc., CRISPR Therapeutics AG, Editas Medicine, Inc., Genscript Biotech Corp., Intellia Therapeutics Inc., and others.

Key Questions Addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global CRISPR Market Report Segment

By Application

• Cell Line Engineering 
• CRISPR Plasmid 
• Gene Database/Gene Library 
• Genetic Engineering 
• Genetically Modified Organisms or Crops
• Genome Editing 
• Human Stem Cells 

By End-User

• Academic Institutes 
• Biotechnology Companies 
• Pharmaceuticals Companies 
• Research and Development Institutes 

Global CRISPR Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Russia

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Australia and New Zealand

• ASEAN Economies

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/crispr-market